Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 216 entries
Sorted by: Best Match Show Resources per page
Ultra-High-Density Arrays of Defect-Free AlN Nanorods: A "Space-Filling" Approach.

ACS nano

Conroy M, Zubialevich VZ, Li H, Petkov N, O'Donoghue S, Holmes JD, Parbrook PJ.
PMID: 26597059
ACS Nano. 2016 Feb 23;10(2):1988-94. doi: 10.1021/acsnano.5b06062. Epub 2016 Jan 25.

Nanostructured semiconductors have a clear potential for improved optoelectronic devices, such as high-efficiency light-emitting diodes (LEDs). However, most arrays of semiconductor nanorods suffer from having relatively low densities (or "fill factors") and a high degree of nonuniformity, especially when...

Cite
Conroy M, Zubialevich VZ, Li H, et al. Ultra-High-Density Arrays of Defect-Free AlN Nanorods: A "Space-Filling" Approach. ACS Nano. 2016;10(2):1988-94doi: 10.1021/acsnano.5b06062.
Conroy, M., Zubialevich, V. Z., Li, H., Petkov, N., O'Donoghue, S., Holmes, J. D., & Parbrook, P. J. (2016). Ultra-High-Density Arrays of Defect-Free AlN Nanorods: A "Space-Filling" Approach. ACS nano, 10(2), 1988-94. https://doi.org/10.1021/acsnano.5b06062
Conroy, Michele, et al. "Ultra-High-Density Arrays of Defect-Free AlN Nanorods: A "Space-Filling" Approach." ACS nano vol. 10,2 (2016): 1988-94. doi: https://doi.org/10.1021/acsnano.5b06062
Conroy M, Zubialevich VZ, Li H, Petkov N, O'Donoghue S, Holmes JD, Parbrook PJ. Ultra-High-Density Arrays of Defect-Free AlN Nanorods: A "Space-Filling" Approach. ACS Nano. 2016 Feb 23;10(2):1988-94. doi: 10.1021/acsnano.5b06062. Epub 2016 Jan 25. PMID: 26597059.
Copy Download .nbib Format: NLM
Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics.

Tropical medicine & international health : TM & IH

Glezeva N, Gallagher J, Ledwidge M, O'Donoghue J, McDonald K, Chipolombwe J, Watson C.
PMID: 25598183
Trop Med Int Health. 2015 May;20(5):581-588. doi: 10.1111/tmi.12461. Epub 2015 Feb 02.

Within Africa, the burden of heart failure is significant. This arises from the increase in cardiovascular disease and associated risk factors such as hypertension and diabetes, as well as causes of heart failure which are particular to sub-Saharan Africa,...

Cite
Glezeva N, Gallagher J, Ledwidge M, et al. Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics. Trop Med Int Health. 2015;20(5):581-588doi: 10.1111/tmi.12461.
Glezeva, N., Gallagher, J., Ledwidge, M., O'Donoghue, J., McDonald, K., Chipolombwe, J., & Watson, C. (2015). Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics. Tropical medicine & international health : TM & IH, 20(5), 581-588. https://doi.org/10.1111/tmi.12461
Glezeva, Nadezhda, et al. "Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics." Tropical medicine & international health : TM & IH vol. 20,5 (2015): 581-588. doi: https://doi.org/10.1111/tmi.12461
Glezeva N, Gallagher J, Ledwidge M, O'Donoghue J, McDonald K, Chipolombwe J, Watson C. Heart failure in sub-Saharan Africa: review of the aetiology of heart failure and the role of point-of-care biomarker diagnostics. Trop Med Int Health. 2015 May;20(5):581-588. doi: 10.1111/tmi.12461. Epub 2015 Feb 02. PMID: 25598183.
Copy Download .nbib Format: NLM
Infective endocarditis in pregnancy: Case report and review of the literature.

Obstetric medicine

Connolly C, O'Donoghue K, Doran H, McCarthy FP.
PMID: 27512463
Obstet Med. 2015 Jun;8(2):102-4. doi: 10.1177/1753495X15572857. Epub 2015 Mar 08.

Infective endocarditis in pregnancy is associated with high maternal and fetal morbidity and mortality and is estimated to complicate approximately 1 in 100,000 pregnancies. We report the case of a 33-year-old patient who presented at 30 weeks and 3...

Cite
Connolly C, O'Donoghue K, Doran H, et al. Infective endocarditis in pregnancy: Case report and review of the literature. Obstet Med. 2015;8(2):102-4doi: 10.1177/1753495X15572857.
Connolly, C., O'Donoghue, K., Doran, H., & McCarthy, F. P. (2015). Infective endocarditis in pregnancy: Case report and review of the literature. Obstetric medicine, 8(2), 102-4. https://doi.org/10.1177/1753495X15572857
Connolly, Catherine, et al. "Infective endocarditis in pregnancy: Case report and review of the literature." Obstetric medicine vol. 8,2 (2015): 102-4. doi: https://doi.org/10.1177/1753495X15572857
Connolly C, O'Donoghue K, Doran H, McCarthy FP. Infective endocarditis in pregnancy: Case report and review of the literature. Obstet Med. 2015 Jun;8(2):102-4. doi: 10.1177/1753495X15572857. Epub 2015 Mar 08. PMID: 27512463; PMCID: PMC4935011.
Copy Download .nbib Format: NLM
Resurgence in home haemodialysis: perspectives from the UK.

NDT plus

Mitra S, Brady M, O'Donoghue D.
PMID: 25949507
NDT Plus. 2011 Dec;4:iii1-iii3. doi: 10.1093/ndtplus/sfr133.

Improvement in dialysis outcomes requires a paradigm shift in haemodialysis provision and service design. Haemodialysis at home, recommended by the National Institute for Health and Clinical Excellence, can lead to outcome benefits but has a range of implementation barriers....

Cite
Mitra S, Brady M, O'Donoghue D. Resurgence in home haemodialysis: perspectives from the UK. NDT Plus. 2011;4:iii1-iii3doi: 10.1093/ndtplus/sfr133.
Mitra, S., Brady, M., & O'Donoghue, D. (2011). Resurgence in home haemodialysis: perspectives from the UK. NDT plus, 4iii1-iii3. https://doi.org/10.1093/ndtplus/sfr133
Mitra, Sandip, et al. "Resurgence in home haemodialysis: perspectives from the UK." NDT plus vol. 4 (2011): iii1-iii3. doi: https://doi.org/10.1093/ndtplus/sfr133
Mitra S, Brady M, O'Donoghue D. Resurgence in home haemodialysis: perspectives from the UK. NDT Plus. 2011 Dec;4:iii1-iii3. doi: 10.1093/ndtplus/sfr133. PMID: 25949507; PMCID: PMC4421464.
Copy Download .nbib Format: NLM
Diverse, yet-to-be-cultured members of the Rubrobacter subdivision of the Actinobacteria are widespread in Australian arid soils.

FEMS microbiology ecology

Holmes AJ, Bowyer J, Holley MP, O'Donoghue M, Montgomery M, Gillings MR.
PMID: 10967210
FEMS Microbiol Ecol. 2000 Aug 01;33(2):111-120. doi: 10.1111/j.1574-6941.2000.tb00733.x.

Phylogenetic analyses of ribosomal RNA gene sequences (rDNAs) retrieved from an Australian desert soil sample (Sturt National Park) revealed the presence of a number of clones which branched deeply from the high GC Gram-positive division line of descent. The...

Cite
Holmes AJ, Bowyer J, Holley MP, et al. Diverse, yet-to-be-cultured members of the Rubrobacter subdivision of the Actinobacteria are widespread in Australian arid soils. FEMS Microbiol Ecol. 2000;33(2):111-120doi: 10.1111/j.1574-6941.2000.tb00733.x.
Holmes, A. J., Bowyer, J., Holley, M. P., O'Donoghue, M., Montgomery, M., & Gillings, M. R. (2000). Diverse, yet-to-be-cultured members of the Rubrobacter subdivision of the Actinobacteria are widespread in Australian arid soils. FEMS microbiology ecology, 33(2), 111-120. https://doi.org/10.1111/j.1574-6941.2000.tb00733.x
Holmes, et al. "Diverse, yet-to-be-cultured members of the Rubrobacter subdivision of the Actinobacteria are widespread in Australian arid soils." FEMS microbiology ecology vol. 33,2 (2000): 111-120. doi: https://doi.org/10.1111/j.1574-6941.2000.tb00733.x
Holmes AJ, Bowyer J, Holley MP, O'Donoghue M, Montgomery M, Gillings MR. Diverse, yet-to-be-cultured members of the Rubrobacter subdivision of the Actinobacteria are widespread in Australian arid soils. FEMS Microbiol Ecol. 2000 Aug 01;33(2):111-120. doi: 10.1111/j.1574-6941.2000.tb00733.x. PMID: 10967210.
Copy Download .nbib Format: NLM
A code of ethics for the medical dosimetrist--the American Association of Medical Dosimetrists experience.

Medical dosimetry : official journal of the American Association of Medical Dosimetrists

Martin L, Baker B, Fairall D, Florell K, Foster A, Gilbert K, O'Donoghue J.
PMID: 9586724
Med Dosim. 1998;23(1):85-6.

The Committee on Protocol and Ethics of the American Association of Medical Dosimetrists (AAMD) has developed a Code of Ethics for a radiation oncology society of medical dosimetrists. The purpose of the code of ethics is fourfold: (1) Establish...

Cite
Martin L, Baker B, Fairall D, et al. A code of ethics for the medical dosimetrist--the American Association of Medical Dosimetrists experience. Med Dosim. 1998;23(1):85-6
Martin, L., Baker, B., Fairall, D., Florell, K., Foster, A., Gilbert, K., & O'Donoghue, J. (1998). A code of ethics for the medical dosimetrist--the American Association of Medical Dosimetrists experience. Medical dosimetry : official journal of the American Association of Medical Dosimetrists, 23(1), 85-6.
Martin, L, et al. "A code of ethics for the medical dosimetrist--the American Association of Medical Dosimetrists experience." Medical dosimetry : official journal of the American Association of Medical Dosimetrists vol. 23,1 (1998): 85-6.
Martin L, Baker B, Fairall D, Florell K, Foster A, Gilbert K, O'Donoghue J. A code of ethics for the medical dosimetrist--the American Association of Medical Dosimetrists experience. Med Dosim. 1998;23(1):85-6. PMID: 9586724.
Copy Download .nbib Format: NLM
ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma.

Clinical molecular pathology

Bennett MA, Kay EW, Mulcahy H, O'flaherty L, O'donoghue DP, Leader M, Croke DT.
PMID: 16696029
Clin Mol Pathol. 1995 Dec;48(6):M310-5. doi: 10.1136/mp.48.6.m310.

Aims-To determine possible associations between p53 allelic deletion, c-Ki-ras mutational activation, immunohistochemical detection of p53 and ras proteins, various clinicopathological variables, and patient outcome in 168 Dukes' stage B colorectal carcinomas.Methods-Allelic deletion at the p53 tumour suppressor gene locus...

Cite
Bennett MA, Kay EW, Mulcahy H, et al. ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma. Clin Mol Pathol. 1995;48(6):M310-5doi: 10.1136/mp.48.6.m310.
Bennett, M. A., Kay, E. W., Mulcahy, H., O'flaherty, L., O'donoghue, D. P., Leader, M., & Croke, D. T. (1995). ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma. Clinical molecular pathology, 48(6), M310-5. https://doi.org/10.1136/mp.48.6.m310
Bennett, M A, et al. "ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma." Clinical molecular pathology vol. 48,6 (1995): M310-5. doi: https://doi.org/10.1136/mp.48.6.m310
Bennett MA, Kay EW, Mulcahy H, O'flaherty L, O'donoghue DP, Leader M, Croke DT. ras and p53 in the prediction of survival in Dukes' stage B colorectal carcinoma. Clin Mol Pathol. 1995 Dec;48(6):M310-5. doi: 10.1136/mp.48.6.m310. PMID: 16696029; PMCID: PMC407996.
Copy Download .nbib Format: NLM
Diagnosis and treatment of injury to the anterior cruciate ligament *.

The Journal of orthopaedic and sports physical therapy

O'Donoghue DH.
PMID: 18810157
J Orthop Sports Phys Ther. 1981;2(3):100-7. doi: 10.2519/jospt.1981.2.3.100.

No abstract available.

Cite
O'Donoghue DH. Diagnosis and treatment of injury to the anterior cruciate ligament *. J Orthop Sports Phys Ther. 1981;2(3):100-7doi: 10.2519/jospt.1981.2.3.100.
O'Donoghue, D. H. (1981). Diagnosis and treatment of injury to the anterior cruciate ligament *. The Journal of orthopaedic and sports physical therapy, 2(3), 100-7. https://doi.org/10.2519/jospt.1981.2.3.100
O'Donoghue, D H. "Diagnosis and treatment of injury to the anterior cruciate ligament *." The Journal of orthopaedic and sports physical therapy vol. 2,3 (1981): 100-7. doi: https://doi.org/10.2519/jospt.1981.2.3.100
O'Donoghue DH. Diagnosis and treatment of injury to the anterior cruciate ligament *. J Orthop Sports Phys Ther. 1981;2(3):100-7. doi: 10.2519/jospt.1981.2.3.100. PMID: 18810157.
Copy Download .nbib Format: NLM
Fractures.

Archives of surgery (Chicago, Ill. : 1920)

STUCK WG, O'DONOGHUE DH.
PMID: 21015448
Arch Surg. 1946 Jan;52:66-98.

No abstract available.

Cite
STUCK WG, O'DONOGHUE DH. Fractures. Arch Surg. 1946;52:66-98
STUCK, W. G., & O'DONOGHUE, D. H. (1946). Fractures. Archives of surgery (Chicago, Ill. : 1920), 5266-98.
STUCK, W G, and O'DONOGHUE, D H. "Fractures." Archives of surgery (Chicago, Ill. : 1920) vol. 52 (1946): 66-98.
STUCK WG, O'DONOGHUE DH. Fractures. Arch Surg. 1946 Jan;52:66-98. PMID: 21015448.
Copy Download .nbib Format: NLM
Anorectal stenosis after treatment with tumor necrosis factor alpha antibodies: a case series.

Journal of medical case reports

Slattery E, Keegan D, O'Donoghue D.
PMID: 20659338
J Med Case Rep. 2010 Jul 26;4:226. doi: 10.1186/1752-1947-4-226.

INTRODUCTION: We identified three patients who developed anorectal stenosis after successful treatment with anti-tumor necrosis factor alpha (anti-TNF-alpha) agents.CASE PRESENTATION: Two patients, a 24-year-old Irish Caucasian man and a 64-year-old Irish Caucasian woman, developed symptoms attributable to anorectal stenosis...

Cite
Slattery E, Keegan D, O'Donoghue D. Anorectal stenosis after treatment with tumor necrosis factor alpha antibodies: a case series. J Med Case Rep. 2010;4:226doi: 10.1186/1752-1947-4-226.
Slattery, E., Keegan, D., & O'Donoghue, D. (2010). Anorectal stenosis after treatment with tumor necrosis factor alpha antibodies: a case series. Journal of medical case reports, 4226. https://doi.org/10.1186/1752-1947-4-226
Slattery, Eoin, et al. "Anorectal stenosis after treatment with tumor necrosis factor alpha antibodies: a case series." Journal of medical case reports vol. 4 (2010): 226. doi: https://doi.org/10.1186/1752-1947-4-226
Slattery E, Keegan D, O'Donoghue D. Anorectal stenosis after treatment with tumor necrosis factor alpha antibodies: a case series. J Med Case Rep. 2010 Jul 26;4:226. doi: 10.1186/1752-1947-4-226. PMID: 20659338; PMCID: PMC2918630.
Copy Download .nbib Format: NLM
Physical Demands of Different Positions in FA Premier League Soccer.

Journal of sports science & medicine

Bloomfield J, Polman R, O'Donoghue P.
PMID: 24149226
J Sports Sci Med. 2007 Mar 01;6(1):63-70. eCollection 2007.

The purpose of this study was to evaluate the physical demands of English Football Association (FA) Premier League soccer of three different positional classifications (defender, midfielder and striker). Computerised time-motion video-analysis using the Bloomfield Movement Classification was undertaken on...

Cite
Bloomfield J, Polman R, O'Donoghue P. Physical Demands of Different Positions in FA Premier League Soccer. J Sports Sci Med. 2007;6(1):63-70
Bloomfield, J., Polman, R., & O'Donoghue, P. (2007). Physical Demands of Different Positions in FA Premier League Soccer. Journal of sports science & medicine, 6(1), 63-70.
Bloomfield, Jonathan, et al. "Physical Demands of Different Positions in FA Premier League Soccer." Journal of sports science & medicine vol. 6,1 (2007): 63-70.
Bloomfield J, Polman R, O'Donoghue P. Physical Demands of Different Positions in FA Premier League Soccer. J Sports Sci Med. 2007 Mar 01;6(1):63-70. eCollection 2007. PMID: 24149226; PMCID: PMC3778701.
Copy Download .nbib Format: NLM
Talimogene laherparepvec: overview, combination therapy and current practices.

Melanoma management

O'Donoghue C, Doepker MP, Zager JS.
PMID: 30190898
Melanoma Manag. 2016 Dec;3(4):267-272. doi: 10.2217/mmt-2016-0021. Epub 2016 Sep 15.

Talimogene laherparepvec (T-VEC, Imlygic

Cite
O'Donoghue C, Doepker MP, Zager JS. Talimogene laherparepvec: overview, combination therapy and current practices. Melanoma Manag. 2016;3(4):267-272doi: 10.2217/mmt-2016-0021.
O'Donoghue, C., Doepker, M. P., & Zager, J. S. (2016). Talimogene laherparepvec: overview, combination therapy and current practices. Melanoma management, 3(4), 267-272. https://doi.org/10.2217/mmt-2016-0021
O'Donoghue, Cristina, et al. "Talimogene laherparepvec: overview, combination therapy and current practices." Melanoma management vol. 3,4 (2016): 267-272. doi: https://doi.org/10.2217/mmt-2016-0021
O'Donoghue C, Doepker MP, Zager JS. Talimogene laherparepvec: overview, combination therapy and current practices. Melanoma Manag. 2016 Dec;3(4):267-272. doi: 10.2217/mmt-2016-0021. Epub 2016 Sep 15. PMID: 30190898; PMCID: PMC6094674.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 216 entries